American Chemical Society (ACS)
In Silico Pharmacophore Study and Structural Optimization of Nafamostat Yield Potentially Novel Transmembrane Protease Serine 2 (TMPRSS2) Inhibitors Which Block the Entry of SARS-CoV-2 Virus into Human Cells
Publication
, Preprint
Nguyen, B
May 21, 2020
Duke Scholars
Citation
APA
Chicago
ICMJE
MLA
NLM
Nguyen, B. (2020). In Silico Pharmacophore Study and Structural Optimization of Nafamostat Yield Potentially Novel Transmembrane Protease Serine 2 (TMPRSS2) Inhibitors Which Block the Entry of SARS-CoV-2 Virus into Human Cells. American Chemical Society (ACS). https://doi.org/10.26434/chemrxiv.12340001.v1
Nguyen, Bach. “In Silico Pharmacophore Study and Structural Optimization of Nafamostat Yield Potentially Novel Transmembrane Protease Serine 2 (TMPRSS2) Inhibitors Which Block the Entry of SARS-CoV-2 Virus into Human Cells.” American Chemical Society (ACS), May 21, 2020. https://doi.org/10.26434/chemrxiv.12340001.v1.
Nguyen, Bach. “In Silico Pharmacophore Study and Structural Optimization of Nafamostat Yield Potentially Novel Transmembrane Protease Serine 2 (TMPRSS2) Inhibitors Which Block the Entry of SARS-CoV-2 Virus into Human Cells.” American Chemical Society (ACS), 21 May 2020. Crossref, doi:10.26434/chemrxiv.12340001.v1.